Effect of buspirone: An anxiolytic drug on blood glucose in humans

Indian Journal of Clinical Biochemistry

Volumn 21, Issue 2, 2006, Pages 58-62

  Ojha, S K ^b   Nandave, M ^b   Sharma, C ^a  

^a DABUR RESEARCH FOUNDATION   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antianxiety drug; Healthy volunteers; Oral glucose load

Indexed keywords

ANXIOLYTIC AGENT; BUSPIRONE; GLUCOSE; HEXOKINASE; INSULIN; PLACEBO; SEROTONIN 1A RECEPTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST;

ANIMALIA;

EID: 33751055787     PISSN: 09701915     EISSN: 09701915     Source Type: Journal    
DOI: 10.1007/BF02912913     Document Type: Article

References (29)

1. Lustman, P.J., Griffith, L.S., Clouse, R.E. and Cryer, P.E. (1986) Psychiatric illness in diabetes mellitus, relationship to symptoms and glucose control. J. Nerve Ment. Dis. 174, 736-742.
2. Popkin, M.K., Callies, A.L., Lentz, R.D., Colon, E.A. and Sutherland, D.E. (1988) Prevalence of major depression, simple phobia and other psychiatric disorders in patients with longstanding type 1 diabetes mellitus. Arch. Gen. Psychiatry 45, 64-68.
3. Simon, N.M. and Pollack, M.H. (1999) Anxiety disorders, in Conn's current therapy, edited by Rakel, R.E. (W. B. Saunders, Philadelphia), 1126.
4. Foster, D.W. (1998) Diabetes mellitus, in Harrison's Principles of Internal Medicine, edited by Fauci, A.S., Martin, J.B., Braunwald, E., Kasper, D.L., Isselbecher, K.J., Hauser, S.L., Wilson, J.D. and Longo, D.L. McGraw Hill USA 2060.
5. nd Edn., Churchill Livingston, New York, pp B114-B117.
6. Nonogaki, K. and Iguchi, A. (1997) Role of central neural mechanisms in the regulation of hepatic glucose metabolism. Life Sci. 60, 797-807.
7. Smith, S.A., Pogson, C.I. Smith S.A., Pogson C.L. (1977) Tryptophan and the control of plasma glucose concentrations in the rat. Biochem. J. 168, 495-506.
8. Chaouloff, F. and Jeanrenacid, B. (1987) 5-HT-1A and adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effect of 8-hydroxy -2-(di-n-propylamino) tetraline in the conscious rat. J. Pharmacol. Exp. Ther. 243, 1159-1166.
9. 2B/2C receptors. Eur. J. Pharmacol. 359, 185-190.
10. Wozanik, K.M. and Linnoila, M. (1991) Hyperglycemic properties of serotonin receptor antagonists. Life Sci. 49, 101-109.
11. 1A agonist action of buspirone in man. Psychopharmacol. 158, 224-227.
12. nd edition edited by Parfitt, K. Pharmaceutical Press, 326.
13. Yamada, J., Sugiomoto, Y., Kimura, I., Wantanabe, Y. and Horisaka, K. (1992) The effect of the serotonin-1A receptors agonist buspirone on the blood glucose and pancreatic hormones in the rats. Jpn. J. Pharmacol. 60, 145-148.
14. Chaouloff, F., Baudrie, V. and Laude, D. (1990) Evidences that the 5-HT 1A receptor agonist buspirone and iprapirone activates adrenaline release in the conscious rat. Eur. J. Pharmacol. 177, 107-110.
15. Sugimoto, Y., Yamada, J., Kimura, I. and Horisaka, K. (1995) The effects of the serotonin 1A agonist buspirone on tolbutamide-induced hypoglycemia in rats. Biol. Pharm. Bull. 18, 1296-1298.
16. Massari, V., Eschwege, E., Valleron, A.J., Massari, V., Eschwege, E. and Valleron, A.J. (1983) Imprecision of new criteria for the oral glucose tolerance test. Diabetologia 24, 100-106.
17. Gammans, R.E., Mayol, R.F. and Labudde, J.A. (1986) Metabolism and disposition of buspirone. Am. J. Med. 80, 41-51.
18. Kunst, A., Drager, B. and Ziagenhorn, J. (1983) UV methods with hexokinase and glucose 6-phosphate dehydrogenase, In Methods of Enzymatic Analysis. 163-172.
19. Willein, T., Nicholsan, S. and Casey, C. (1985) A micro enzyme-linked immunosorbent assay for insulin antibodies in serum. J. Immunol. Methods 76, 185-194.
20. Furman, B.L., (1980) Impairment of glucose tolerance produced by diuretics and other drugs. Pharmacol. Ther. 12, 613-640.
21. Lundiquist, I., Ahren, B. and Hankson, R. (1989) Monoamines in pancreatic islets of guinea pig, hamster, rat and mouse determined by high performance liquid chromatography. Pancreas 4, 662-667.
22. Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mytecharane, E.J., Saxena, P.R. and Humphrey, P.R. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157-203.
23. Furman, B.L. and Wilson, G.A. (1980) Further studies on the effects of 5- hydroxytryptophan on plasma glucose and insulin in the mouse. Diabetologia 19, 386-390.
24. Yamada, J., Sugimoto, Y., Kimura, I., Tekeuchi, N. and Horisaka, K. (1989) Serotonin induced hypoglycemia and increased plasma insulin levels in mice. Life Sci. 45, 1931-1936.
25. Uvnas-moberg, K., Ahlenius, S., Alstel, P. and Hillegart, V. (1996) Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat. Neuroendocrinol. 63, 269-274.
26. Dixit, R.K., Puri, J.N., Sharma, M.K., Jain, I.P., Singh, S., Ansari, N.A. and Singh, S.P. (2001) Effect of anxiolytics on blood sugar level in rabbits. Indian J. Exp. Biol. 39, 378-380.
27. 1A receptor agonist 8-OH-DPAT on plasma levels of insulin, cholecystokinin and somatostatin. Regul. Pept. 63, 47-52.
28. Breum, L., Bjerre, U., Bak, J.F., Jacobson, S. and Astrup, A. (1995) Long term effects of fluoxetine on glycemic control in obese patients with non-insulin-dependent diabetes mellitus or glucose intolerance: influence on muscle glycogen synthase and insulin receptor kinase activity. Metabolism 44, 1570-1576.
29. Martin, F.J., Miguez, J.M., Aldegunde, M. and Atienza, G. (1995) Effect of streptozotocin-induced diabetes mellitus on serotonin measured of peripheral tissues in rats. Life Sci. 56, 51-59.